Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04500548
Status:
WITHDRAWN
Last Update Posted:
2022-09-10
First Post:
2020-08-04
Brief Title:
Testing the Combination of Two Immunotherapy Drugs Nivolumab and Ipilimumab in Children Adolescent and Young Adult Patients With RelapsedRefractory Cancers That Have an Increased Number of Genetic Changes The 3CI Study
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
NCI-2020-05617
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None